New York, NY—March 31, 2010
Previously the head of the Special Projects and Education committee, Dr. Goldring was chosen by the members of the Orthopaedic Research Society (ORS) over a number of other candidates through an election process. The organization’s membership is composed of orthopedists, basic scientists and bioengineers and they strive to have a board that is representative of their membership. Dr. Goldring will represent the basic sciences in her position. She is also currently a co-editor for the journal Arthritis & Rheumatism and a board member of the Osteoarthritis Research Society International.
Dr. Goldring’s research is focused on cartilage, the tissue within the joints that provides cushioning. Her work explores the basic biology of the tissue and its individual cells, called chondrocytes, both in its normal state and when it is damaged, as in osteoarthritis, the leading cause of joint replacement surgery. Understanding, at a mechanistic and genetic level, how cartilage tissue develops and and responds to mechanical and inflammatory stress may provide insight into approaches to slow cartilage damage, if not help stimulate repair.
About Hospital for Special Surgery
Hospital for Special Surgery (HSS) is the world’s leading academic medical center focused on musculoskeletal health. HSS is nationally ranked No. 1 in orthopedics and No. 3 in rheumatology by U.S. News & World Report (2017-2018), and is the first hospital in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. HSS has one of the lowest infection rates in the country. HSS is an affiliate of Weill Cornell Medical College and as such all Hospital for Special Surgery medical staff are faculty of Weill Cornell. The hospital's research division is internationally recognized as a leader in the investigation of musculoskeletal and autoimmune diseases. HSS has locations in New York, New Jersey and Connecticut.